A novel contiguous deletion involving NDP, MAOB and EFHC2 gene in a patient with familial Norrie disease: bilateral blindness and leucocoria without other deficits.

Contiguous microdeletions of the Norrie disease pseudoglioma (NDP) region on chromosome Xp11.3 have been widely confirmed as contributing to the typical clinical features of Norrie disease (ND). However, the precise relation between genotype and phenotype could vary. The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy. Herewe report a novel contiguous microdeletion of the NDP region containing the MAOB and EFHC2 genes,which causes eye defects but no cognitive disability.We detected a deletion of 494.6 kb atXp11.3 in both the proband and carrier mother. This deletionwas then used as the molecular marker in prenatal diagnosis for two subsequent pregnancies. The deletion was absent in one of the foetuses, who remain without any abnormalities at 2 years of age. The proband shows the typical ocular clinical features of ND including bilateral retinal detachment, microphthalmia, atrophic irides, corneal opacification, and cataracts, but no symptoms of microcephaly, intellectual disability, and epilepsy. This familial study demonstrates that a deficiency in one of two MAO genes may not lead to psychomotor delay, and deletion of EFHC2 may not cause epilepsy. Our observations provide new information on the genotype-phenotype relations of MAOA/B and EFHC2 genes involved in the contiguous deletions of ND.

[1]  B. Ferda,et al.  No relation between EFHC2 gene polymorphism and Idiopathic generalized epilepsy. , 2016, African Health Sciences.

[2]  Ayumi Matsumoto,et al.  MAOA/B deletion syndrome in male siblings with severe developmental delay and sudden loss of muscle tonus , 2014, Brain and Development.

[3]  Ryan D. Darling,et al.  Monoamine oxidase A and A/B knockout mice display autistic-like features. , 2013, The international journal of neuropsychopharmacology.

[4]  P. Reddy,et al.  Multi-functional norrin is a ligand for the LGR4 receptor , 2013, Journal of Cell Science.

[5]  J. Nathans,et al.  Norrin/Frizzled4 Signaling in Retinal Vascular Development and Blood Brain Barrier Plasticity , 2012, Cell.

[6]  Dionne A. Graham,et al.  Norrie disease: Extraocular clinical manifestations in 56 patients , 2012, American journal of medical genetics. Part A.

[7]  K. Sims,et al.  Co-segregation of Norrie disease and idiopathic pulmonary hypertension in a family with a microdeletion of the NDP region at Xp11.3-p11.4 , 2010, Journal of Medical Genetics.

[8]  F. Cremers,et al.  Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP , 2010, Human mutation.

[9]  E. Pelcastre,et al.  Novel and recurrent NDP gene mutations in familial cases of Norrie disease and X‐linked exudative vitreoretinopathy , 2010, Clinical and Experimental Ophthalmology.

[10]  J. Ellison,et al.  A Novel NDP Mutation in an Infant with Unilateral Persistent Fetal Vasculature and Retinal Vasculopathy , 2009, Ophthalmic genetics.

[11]  L. Armengol,et al.  Contiguous deletion of the NDP, MAOA, MAOB, and EFHC2 genes in a patient with Norrie disease, severe psychomotor retardation and myoclonic epilepsy , 2007, American journal of medical genetics. Part A.

[12]  A. Heils,et al.  A new EF-hand containing gene EFHC2 on Xp11.4: Tentative evidence for association with juvenile myoclonic epilepsy , 2005, Epilepsy Research.

[13]  A H van Gennip,et al.  Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. , 1996, The Journal of clinical investigation.

[14]  M. Salcedo,et al.  A missense point mutation (Leu13Arg) of the Norrie disease gene in a large Cuban kindred with Norrie disease. , 1994, Human molecular genetics.

[15]  A. Fielder,et al.  A mutation in the Norrie disease gene (NDP) associated with X–linked familial exudative vitreoretinopathy , 1993, Nature genetics.

[16]  A. Monaco,et al.  Isolation of a candidate gene for Norrie disease by positional cloning , 1992, Nature Genetics.

[17]  A. Chapelle,et al.  Monoamine oxidase deficiency in males with an X chromosome deletion , 1989, Neuron.

[18]  A. Read,et al.  Norrie disease resulting from a gene deletion: clinical features and DNA studies. , 1988, Journal of medical genetics.

[19]  D. Murphy,et al.  Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. , 1992, American journal of medical genetics.

[20]  H. Ropers,et al.  Submicroscopic interstitial deletion of the X chromosome explains a complex genetic syndrome dominated by Norrie disease. , 1986, Cytogenetics and cell genetics.